1. Home
  2. SQFT vs MBIO Comparison

SQFT vs MBIO Comparison

Compare SQFT & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQFT
  • MBIO
  • Stock Information
  • Founded
  • SQFT 1999
  • MBIO 2015
  • Country
  • SQFT United States
  • MBIO United States
  • Employees
  • SQFT N/A
  • MBIO N/A
  • Industry
  • SQFT Real Estate Investment Trusts
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQFT Real Estate
  • MBIO Health Care
  • Exchange
  • SQFT Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • SQFT 8.3M
  • MBIO 7.3M
  • IPO Year
  • SQFT 2020
  • MBIO N/A
  • Fundamental
  • Price
  • SQFT $0.65
  • MBIO $2.81
  • Analyst Decision
  • SQFT
  • MBIO Strong Buy
  • Analyst Count
  • SQFT 0
  • MBIO 1
  • Target Price
  • SQFT N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • SQFT 28.4K
  • MBIO 410.6K
  • Earning Date
  • SQFT 02-18-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • SQFT N/A
  • MBIO N/A
  • EPS Growth
  • SQFT N/A
  • MBIO N/A
  • EPS
  • SQFT N/A
  • MBIO N/A
  • Revenue
  • SQFT $18,586,052.00
  • MBIO N/A
  • Revenue This Year
  • SQFT N/A
  • MBIO N/A
  • Revenue Next Year
  • SQFT N/A
  • MBIO N/A
  • P/E Ratio
  • SQFT N/A
  • MBIO N/A
  • Revenue Growth
  • SQFT 5.44
  • MBIO N/A
  • 52 Week Low
  • SQFT $0.47
  • MBIO $2.78
  • 52 Week High
  • SQFT $1.39
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • SQFT 42.13
  • MBIO 28.00
  • Support Level
  • SQFT $0.64
  • MBIO $3.96
  • Resistance Level
  • SQFT $0.72
  • MBIO $6.70
  • Average True Range (ATR)
  • SQFT 0.05
  • MBIO 0.97
  • MACD
  • SQFT -0.00
  • MBIO -0.12
  • Stochastic Oscillator
  • SQFT 17.14
  • MBIO 2.83

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: